Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT03102177Phase 1Completed
Phase 1, open-label, single-arm trial of levothyroxine sodium in hypothyroidism, sponsored by Georgetown University. Primary endpoints: Apparent Clearance at 120 hours, Apparent Volume of Distribution at 120 hours and 1 more. Started May 2011; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT03102177.